期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

系统性红斑狼疮生物制剂治疗的研究进展 被引量：2

暂未订购
导出
摘要 系统性红斑狼疮是一种常见病和多发病 ,目前仍缺乏安全、有效的治疗方法。近年来基础免疫学的发展使生物制剂治疗甚至治愈系统性红斑狼疮成为可能 ,现就这一方面的进展做一介绍。
作者 郝进 郝飞
机构地区 第三军医大学西南医院皮肤科
出处 《国外医学（皮肤性病学分册）》 2002年第4期208-211,共4页 Foreign Medical Sciences(Section of Dermatology and Venereology)
关键词 系统性红斑狼疮 生物学 治疗 SLE 基因治疗 造血干细胞移植治疗 Th细胞表位疫苗
分类号 R593.241 [医药卫生—内科学]
  • 相关文献

参考文献17

  • 1Ruiz-Irastorza G, Khamashta MA, Castellino G, et al. Systemic lupus erythematosus. Lancet, 2001,357 (9261): 1027-1032.
  • 2Mohan C, Shi Y, Laman JD,et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol, 1995,154(3): 1470-1480.
  • 3Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science, 1994,265(5176): 1225-1227.
  • 4Sfikakis PP, Via CS. Expression of CD28, CTLA4, CD80, and CD86molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy. Clin Immunol Immunopathol, 1997,83(3 ): 195-198.
  • 5Liblau R, Tisch R, Bercovici N,et al. Systemic antigen in the treatment of T- cell- mediated autoimmune diseases. Immunol Today, 1997,18 ( 12 ): 599 -604.
  • 6Zimmerman R, Radhakrishnan J, Valeri A, et al. Advances in the treatment of lupus nephritis. Annu Rev Med,2001,52:63-78.
  • 7Strand V, Lee M. Intravenous immunoglobulin in the treatment of autoimmune disease. In Strand V, Scott DL, Simon LS: Novel therapeutic agents for the treatment of autoimmune disease. New York: Dekker, 1997.235-256.
  • 8Weisman MH, Bluestein HG, Bemer CM, et al. Reduction in circulating dsDNA antibody titer after administration of LJP 394. J Rheumatol, 1997,24(2) :314-318.
  • 9Tumlin JA. Lupus nephritis: novel immunosuppressive modalities and future directions. Semin Nephrol, 1999,19(1) :67-76.
  • 10Pan CQ, Dodge TH, Baker DL,et al. Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus. J Biol Chem, 1998,273 ( 29 ): 18374-18381.

同被引文献13

  • 1Ortmann RA, Klippel JH. Update on cyclophosphamide for systemic lupus erythematosus. Rheum Dis Clin North Am, 2000,26: 363-375.
  • 2McMurray RW. Nonstandard and adjunctive medical therapies for systemic lupus erythematosus. Arthritis Rheum, 2001, 45: 86-100.
  • 3Guma M, Olive A, Roca J, et al. Association of systemic lupus erythematosus and hypermobility. Ann Rheun Dis, 2002, 61:1024-1026.
  • 4Stoll T, Stucki G, Malik J, et al. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol, 1997, 24: 309-313.
  • 5Rapp CA, Berner B, Muller GA, et al.Long-term analysis of clinical disease activity and chronic organ damage in patients with systemic lupus erythematosus. Z Rheumatol, 2002, 61: 521-531.
  • 6Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
  • 7Gladman DD, Urowitz MB, Kagal A, et al.Accurately describing changes in disease activity in Systemic Lupus Erythematosus. J Rheumatol, 2000, 27: 377-379.
  • 8Smolen JS. Therapy of systemic lupus erythematosus: a look into the future. Arthritis Res, 2002, 4 Suppl 3: S25-30.
  • 9[No authors listed]. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.Arthritis Rheum, 1999, 42: 17g5-1796.
  • 10Badsha H, Edwards CJ. Intravenous pulses of methylprednisolone for systemic lupus erythematosus. Semin Arthritis Rheum,2003, 32: 370-377.

引证文献2

二级引证文献26

国外医学（皮肤性病学分册）
2002年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部